Sculptor Capital LP - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOT and the CUSIP is G1125A108. A total of 29 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Sculptor Capital LP ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$3,035,404
+1.8%
300,5380.0%0.05%
+43.2%
Q3 2022$2,981,000
+0.3%
300,538
+0.1%
0.04%
+15.6%
Q2 2022$2,972,000
+0.5%
300,240
+0.1%
0.03%
+39.1%
Q1 2022$2,958,000
+0.2%
300,0000.0%0.02%
-8.0%
Q4 2021$2,952,000
+1.0%
300,0000.0%0.02%
+4.2%
Q3 2021$2,922,000
+0.7%
300,0000.0%0.02%
+14.3%
Q2 2021$2,901,000
-0.5%
300,0000.0%0.02%
-12.5%
Q1 2021$2,916,000300,0000.02%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2021
NameSharesValueWeighting ↓
RiverPark Advisors, LLC 799,001$8,069,9103.84%
Corbin Capital Partners, L.P. 928,124$9,373,9602.85%
Arena Capital Advisors, LLC- CA 300,000$3,029,9701.65%
RPO LLC 359,009$3,625,9551.24%
Alpha Wave Global, LP 532,570$5,378,9570.98%
MMCAP International Inc. SPC 599,321$6,053,0820.61%
GLAZER CAPITAL, LLC 2,283,910$23,0670.60%
GRITSTONE ASSET MANAGEMENT LLC 39,247$396,3910.50%
CVI Holdings, LLC 292,563$2,954,8860.38%
FIR TREE CAPITAL MANAGEMENT LP 635,837$6,421,9540.33%
View complete list of BIOTECH ACQUISITION COMPANY shareholders